Last reviewed · How we verify
Magnesium sulphate and Lidocaine infusion
Magnesium sulphate and Lidocaine infusion is a Small molecule drug developed by Hospital de Base. It is currently FDA-approved. Also known as: Magnesium sulphate, Lidocaine hydrochloride.
At a glance
| Generic name | Magnesium sulphate and Lidocaine infusion |
|---|---|
| Also known as | Magnesium sulphate, Lidocaine hydrochloride |
| Sponsor | Hospital de Base |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Relationship Between Opioid-Free Anesthesia and Postoperative Agitation-Delirium and Quality of Recovery in Pediatric Ear, Nose, and Throat Cases Monitored With Perioperative Bispectral Index
- Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery
- Magnesium Sulfate Versus Other Anesthesia Drugs to Reduce Agitation After Adenotonsillectomy in Pediatric Patients (NA)
- Intravenous Lidocaine, Ketamine, and Magnesium in Thoracic Surgery
- Lidocaine vs Magnesium Sulfate for Hemodynamic Stability During Emergence in Infertility-Related Laparoscopic Surgery" (NA)
- Comparing Intravenous and Intramuscular Magnesium Sulphate for Preventing Seizure Recurrence in Women With Eclampsia (PHASE4)
- Lidocaine Infusion Versus Magnesium Infusion in Decreasing Fentanyl Requirements in Endoscopic Sinus Surgeries (PHASE4)
- Opioid Free Anesthesia in Shoulder Arthroscope (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Magnesium sulphate and Lidocaine infusion CI brief — competitive landscape report
- Magnesium sulphate and Lidocaine infusion updates RSS · CI watch RSS
- Hospital de Base portfolio CI
Frequently asked questions about Magnesium sulphate and Lidocaine infusion
What is Magnesium sulphate and Lidocaine infusion?
Magnesium sulphate and Lidocaine infusion is a Small molecule drug developed by Hospital de Base.
Who makes Magnesium sulphate and Lidocaine infusion?
Magnesium sulphate and Lidocaine infusion is developed and marketed by Hospital de Base (see full Hospital de Base pipeline at /company/hospital-de-base).
Is Magnesium sulphate and Lidocaine infusion also known as anything else?
Magnesium sulphate and Lidocaine infusion is also known as Magnesium sulphate, Lidocaine hydrochloride.
What development phase is Magnesium sulphate and Lidocaine infusion in?
Magnesium sulphate and Lidocaine infusion is FDA-approved (marketed).
Related
- Manufacturer: Hospital de Base — full pipeline
- Also known as: Magnesium sulphate, Lidocaine hydrochloride
- Compare: Magnesium sulphate and Lidocaine infusion vs similar drugs
- Pricing: Magnesium sulphate and Lidocaine infusion cost, discount & access